← Browse by Condition
Medical Condition
aml acute myelogenous leukemia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
NCT06874257
Recruiting
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
Enrollment
20 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT06783790 Phase 2
Recruiting
Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT
Enrollment
20 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT06835140 Phase 1
Recruiting
CD123-CD16-NK Cells Immunotherapy for AML
Enrollment
9 pts
Location
China
Sponsor
Chunji Gao